Thanks.My main concern is not reporting the patient numbers and...

First 7 Last

Share
Profile

Follow
ma420

8,391 Posts.

2096

14/04/25

10:34

Post #: 78677563
Share

Originally posted by Dimitrios63: ↑

Lets take a closer look.

The announcement from Cleo Diagnostics Ltd appears to be positive, highlighting several key developments in their Ovarian Cancer diagnostic test development.

- Progress in Technology
Transfer and Manufacturing The company has commenced technology transfer to a manufacturer and partnered with R&D Systems, Inc., indicating progress toward commercial production.

- Clinical Trials
Advancement Ongoing patient recruitment in the US brings the company closer to generating clinical evidence required for FDA submission.
However the company remains a closed book patient numbers, sampling and testing, as they prefer to make the grand reveal at the appropriate time.
They mentioned the data from interim analysis will be key but no actual timeframe.

- Regulatory Submission
The company remains on track to finalize its FDA submission in CY2026, potentially paving the way for market entry in the US and Australia.
So they have pushed this from CY2025.

- Strong Cash Position With $6.425m in cash reserves, 7 quarters, the company is well-positioned to continue development and commercialization efforts.

Overall, the announcement suggests that Cleo Diagnostics is making meaningful progress in its development efforts, which could be viewed as a positive development for the company and its stakeholders.

Expand

Thanks.

My main concern is not reporting the patient numbers and moving of the timeline from mid-2025 to CY 2026 without commentary.

COV Price at posting: 40.5¢ Sentiment: Buy Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Local bourse tipped to trade red after same on S&P500

WC8

Investors shrug as Wildcat's latest lithium drill hits fail to excite

MHK

Metal Hawk shares sink -50% as gold drill results disappoint

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

SGQ

Traders watch with interest as St George Mining reveals REE hit

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 40.0¢		Change 0.000(0.00%)		Mkt cap ! $32.64M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
4	65903	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
40.0¢	26783	2

View Market Depth

No.	Vol.	Price($)
4	65903	0.375
1	20000	0.370
3	50912	0.365
1	8336	0.360
2	28000	0.350

Price($)	Vol.	No.
0.400	26783	2
0.405	25000	1
0.410	49119	2
0.415	33124	1
0.420	82092	2

Last trade - 10.32am 31/07/2025 (20 minute delay)

COV (ASX) Chart

Day chart unavailable

Thanks.My main concern is not reporting the patient numbers and...

ASX Market Open: Local bourse tipped to trade red after same on S&P500

Investors shrug as Wildcat's latest lithium drill hits fail to excite

Metal Hawk shares sink -50% as gold drill results disappoint

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Traders watch with interest as St George Mining reveals REE hit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks.My main concern is not reporting the patient numbers and...

Top Stories

ASX Market Open: Local bourse tipped to trade red after same on S&P500

Investors shrug as Wildcat's latest lithium drill hits fail to excite

Metal Hawk shares sink -50% as gold drill results disappoint

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Traders watch with interest as St George Mining reveals REE hit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News